Paper

Bacitracin: an inhibitor of the insulin degrading activity of glutathione-insulin transhydrogenase.

Published Jan 30, 1981 · R. Roth

Biochemical and biophysical research communications

102

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro StudyHighly Cited

Study Snapshot

Bacitracin inhibits the insulin degrading activity of glutathione-insulin transhydrogenase, potentially explaining its inhibitory effects on insulin degradation by target cells.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Bacitracin: an inhibitor of the insulin degrading activity of glutathione-insulin transhydrogenase.

References

Citations